Framingham Heart Study
The Framingham Heart Study encourages the interest and proposals of investigators in order to maximize the scientific value of epidemiologic data from the more than 15,000 individuals who have enrolled in FHS over the past seven decades.
About FHS - Framingham Heart Study
Our Study began in 1948 by recruiting an Original Cohort of 5,209 men and women between the ages of 30 and 62 from the town of Framingham, Massachusetts, who had not yet developed overt symptoms of cardiovascular disease or suffered a heart attack or stroke.
History - Framingham Heart Study
In 1948, the Framingham Heart Study – under the direction of the National Heart Institute (now known as the National Heart, Lung, and Blood Institute or NHLBI) – embarked on an ambitious project in health research.
Available FHS Data - Framingham Heart Study
The Framingham Heart Study (FHS) is an epidemiologic study begun in Framingham in 1948 with 5,209 men and women. Since that time the FHS has studied three generations of participants resulting in biological specimens and data from nearly 15,000 participants.
Research Milestones - Framingham Heart Study
Framingham Heart Study researchers contribute to discovering hundreds of new genes underlying major heart disease risk factors—body mass index, blood cholesterol, cigarette smoking, blood pressure and glucose/diabetes
Participants - Framingham Heart Study
There are six groups of participants in the Framingham Heart Study. They are the Original Cohort, Offspring Cohort, Omni Generation 1 Cohort, Third Generation Cohort, New Offspring Spouse Cohort, and Omni Generation 2 Cohort.
Epidemiological Background | Framingham Heart Study
We reviewed the background of the Framingham Heart Study. It did not develop without problems. However, it did develop and it has continued to yield valuable information for over 40 years. The combined efforts of federal, state and local agencies have no better example of how well they can work together and how productive they can be. References
2024 | Framingham Heart Study
The Framingham Heart Study is supported by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health and Boston University Chobanian & Avedisian School of Medicine, under NIH award 75N92019D00031.
Cardiovascular Disease (10-year risk) - Framingham Heart Study
The Framingham Heart Study recommends the 2018 Prevention Guidelines Tool CV Risk Calculator to calculate to estimate 10-year and lifetime risks for atherosclerotic cardiovascular disease (ASCVD). This 2018 calculator has been provided by t he American Heart Association and the American College of Cardiology.
FHS CELEBRATING ITS 75TH ANNIVERSARY - Framingham Heart …
On September 29, 2023, the Framingham Heart Study celebrated its 75th anniversary. In 1948, under the direction of the National Health Institute (now the National Heart, Lung and Blood Institute of the NIH), researchers of the Framingham Heart Study opened its doors and recruited 5,209 men and women, about two-thirds of town’s adult population.